A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/31 (2006.01) A61K 38/08 (2006.01) A61K 38/12 (2006.01) A61K 38/18 (2006.01) C07K 7/02 (2006.01) C07K 7/04 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C07K 14/655 (2006.01)
Patent
CA 2450446
The present invention is directed to a method of reducing the rate of proliferation of adenoma cells which method comprises contacting said pituitary adenoma cells with one or more of an SSTR1 agonist, and/or one or more of an SSTR2 agonist, and/or one or more of SSTR5 agonist, or one or more pharmaceutically acceptable salts thereof, either alone or in combination.
La présente invention concerne une méthode de réduction du taux de prolifération de cellules d'adénome. Ladite méthode consiste à mettre en contact lesdites cellules d'adénomes hypophysaires avec un ou plusieurs agoniste (s) de récepteur de type 1 de la somatostatine (sst1) et/ou une ou plusieurs agoniste(s) de récepteur de type 2 de la somatostatine (sst2), et/ou un ou plusieurs agoniste(s) de récepteur de type 5 de la somatostatine (sst5), ou un ou plusieurs de leurs sels pharmaceutiquement acceptables, soit seuls soit en combinaison
Culler Michael D.
Degliuberti Ettore C.
Zatelli Maria C.
Il Consorzio Ferrara Richerche
Ipsen Pharma S.a.s
Smart & Biggar
Societe de Conseils de Recherches Et D'applications Scientifique
LandOfFree
Pharmaceutical compositions which inhibit proliferation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions which inhibit proliferation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions which inhibit proliferation of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1829741